hi all

below is a summary listing of medical article citations
which contain references to Parkinson's disease and which
have been added to the PubMed WWWeb site in the past 30 days at:
<http://www.ncbi.nlm.nih.gov/PubMed/>

entering the PMID number in the search window there
will take you to an abstract [synopsis] of the article
[if one is available on-line]

in any case,
the full articles are accessible directly from the relevant medical journal
maybe on the web [at a cost] or at a good library [at no cost]
or maybe even at your own neurologist's office!


EDUCATION + TITRATION R US

janet

------------------------------------------------------------------------
 Bezard E, et al.
     Effect of the alpha 2 adrenoreceptor antagonist, idazoxan, on motor
     disabilities in MPTP-treated monkey.
     Prog Neuropsychopharmacol Biol Psychiatry. 1999 Oct;23(7):1237-46.
     PMID: 10581645; UI: 20048346.

 Stack E, et al.
     Fall events described by people with Parkinson's disease: implications
     for clinical interviewing and the research agenda.
     Physiother Res Int. 1999;4(3):190-200.
     PMID: 10581625; UI: 20048326.

 Taylor CA, et al.
     Environmental, medical, and family history risk factors for
     Parkinson's disease: A New England-based case control study.
     Am J Med Genet. 1999 Dec 15;88(6):742-749.
     PMID: 10581500.

 Schraen-Maschke S, et al.
     Analysis of ERDA1, CTG18.1, and uncloned CAG/CTG repeat sequences in
     familial Parkinson's disease with anticipation.
     Am J Med Genet. 1999 Dec 15;88(6):738-741.
     PMID: 10581499.

 Kuhn DM, et al.
     L-DOPA-quinone inactivates tryptophan hydroxylase and converts the
     enzyme to a redox-cycling quinoprotein.
     Brain Res Mol Brain Res. 1999 Nov 10;73(1-2):78-84.
     PMID: 10581400.

 Schmidt J, et al.
     Regulation of heme oxygenase-1 expression by dopamine in cultured C6
     glioma and primary astrocytes.
     Brain Res Mol Brain Res. 1999 Nov 10;73(1-2):50-59.
     PMID: 10581397.

 Gerschlager W, et al.
     Bilateral subthalamic nucleus stimulation improves frontal cortex
     function in Parkinson's disease: An electrophysiological study of the
     contingent negative variation.
     Brain. 1999 Dec;122(12):2365-2373.
     PMID: 10581229.

 York MK, et al.
     Neuropsychological outcome following unilateral pallidotomy.
     Brain. 1999 Dec;122(12):2209-2220.
     PMID: 10581217.

 Liberatore GT, et al.
     Inducible nitric oxide synthase stimulates dopaminergic
     neurodegeneration in the MPTP model of Parkinson disease.
     Nat Med. 1999 Dec;5(12):1403-1409.
     PMID: 10581083.

 Grunewald T, et al.
     NOS knockouts and neuroprotection.
     Nat Med. 1999 Dec;5(12):1354-1355.
     PMID: 10581072.

 Linda H, et al.
     Expression of MHC class I heavy chain and beta2-microglobulin in rat
     brainstem motoneurons and nigral dopaminergic neurons.
     J Neuroimmunol. 1999 Nov 1;101(1):76-86.
     PMID: 10580816; UI: 20046783.

 Mizruchin A, et al.
     Comparison of the effects of dopaminergic and serotonergic activity in
     the CNS on the activity of the immune system.
     J Neuroimmunol. 1999 Nov 15;101(2):201-4.
     PMID: 10580803; UI: 20046770.

 Aguirre JA, et al.
     A stereological study on the neuroprotective actions of acute
     modafinil treatment on MPTP induced nigral lesions of
     the male black mouse.
     Neurosci Lett. 1999 Nov 19;275(3):215-8.
     PMID: 10580713; UI: 20046680.

 Kodama Y, et al.
     Auditory brainstem responses in patients with autonomic failure with
     Parkinson's disease and multiple system atrophy.
     J Auton Nerv Syst. 1999 Sep 24;77(2-3):184-9.
     PMID: 10580301; UI: 20046246.

 Huebscher KJ, et al.
     Protein isoaspartyl methyltransferase protects from Bax-induced
     apoptosis.
     Gene. 1999 Nov 29;240(2):333-341.
     PMID: 10580153.

 Cenci MA, et al.
     Changes in the regional and compartmental distribution of FosB- and
     JunB-like immunoreactivity induced in the dopamine-denervated rat
     striatum by acute or chronic L-dopa treatment.
     Neuroscience. 1999;94(2):515-27.
     PMID: 10579213; UI: 20043814.

 Tarazi F, et al.
     Dopamine D4 receptors: significance for molecular psychiatry at the
     millennium.
     Mol Psychiatry. 1999 Nov;4(6):529-538.
     PMID: 10578234.

 Schulze J, et al.
     Clindamycin and nicotinic neuromuscular transmission.
     Lancet. 1999 Nov 20;354(9192):1792-3.
     PMID: 10577648; UI: 20043580.

 Kraft E, et al.
     Visual hallucinations, white matter lesions and disease severity in
     Parkinson's disease.
     Acta Neurol Scand. 1999 Jun;99(6):362-7.
     PMID: 10577270; UI: 99314579.

 Helmuth L.
     Fetal cells help Parkinson's patients.
     Science. 1999 Oct 29;286(5441):886-7. No abstract available.
     PMID: 10577234; UI: 20041510.

 Baggott M, et al.
     More about parkinsonism after taking ecstasy.
     N Engl J Med. 1999 Oct 28;341(18):1400-1. No abstract available.
     PMID: 10577097; UI: 99450931.

 Mazzoni P, et al.
     The freezing of time as a presenting symptom of Parkinson's disease.
     N Engl J Med. 1999 Oct 21;341(17):1317-8. No abstract available.
     PMID: 10577086; UI: 99442293.

 Bhatia KP, et al.
     Botulinum toxin is a useful treatment in excessive drooling in saliva.
     J Neurol Neurosurg Psychiatry. 1999 Nov;67(5):697. No abstract
     available.
     PMID: 10577041; UI: 20035692.

 Seibyl JP.
     Single-photon emission computed tomography of the dopamine transporter
     in parkinsonism.
     J Neuroimaging. 1999 Oct;9(4):223-8.
     PMID: 10540602; UI: 20008107.

 Zakzanis KK, et al.
     A neuropsychological comparison of demented and nondemented patients
     with Parkinson's disease.
     Appl Neuropsychol. 1999;6(3):129-46.
     PMID: 10497689; UI: 99427339.

 Kienzl E, et al.
     Iron as catalyst for oxidative stress in the pathogenesis of
     Parkinson's disease?
     Life Sci. 1999;65(18-19):1973-6.
     PMID: 10576448; UI: 20041867.

 Beuter A, et al.
     Using frequency domain characteristics to discriminate physiologic and
     parkinsonian tremors.
     J Clin Neurophysiol. 1999 Sep;16(5):484-94.
     PMID: 10576231; UI: 20041650.

 Pennathur S, et al.
     Mass Spectrometric Quantification of 3-Nitrotyrosine, ortho-Tyrosine,
     and o,o'-Dityrosine in Brain Tissue of MPTP treated Mice, a Model of
     Oxidative Stress in Parkinson's Disease.
     J Biol Chem. 1999 Dec 3;274(49):34621-34628.
     PMID: 10574926.

 Cutillas B, et al.
     Caspase inhibition protects nigral neurons against 6-OHDA-induced
     retrograde degeneration.
     Neuroreport. 1999 Aug 20;10(12):2605-8.
     PMID: 10574377; UI: 20039534.

 Pierantozzi M, et al.
     The effect of deep brain stimulation on the frontal N30 component of
     somatosensory evoked potentials in advanced Parkinson's disease
     patients.
     Clin Neurophysiol. 1999 Oct;110(10):1700-7.
     PMID: 10574285; UI: 20039442.

 Sabate M, et al.
     Vitiligo associated with tolcapone and levodopa in a patient with
     Parkinson's disease.
     Ann Pharmacother. 1999 Nov;33(11):1228-9. No abstract available.
     PMID: 10573327; UI: 20037998.

 Frank W, et al.
     Low dose cabergoline induced interstitial pneumonitis.
     Eur Respir J. 1999 Oct;14(4):968-70.
     PMID: 10573251; UI: 20037922.

 Rudolf J, et al.
     Deterioration of parkinsonian symptoms following treatment of
     dopaminergic hallucinosis with olanzapine.
     Eur Psychiatry. 1999 Oct;14(6):356-7.
     PMID: 10572371; UI: 20048779.

 Berger HJ, et al.
     Relationship between Memory Strategies and Motor Symptoms in
     Parkinson's Disease.
     J Clin Exp Neuropsychol. 1999 Oct;21(5):677-684.
     PMID: 10572286.

 Martinez-Martin P, et al.
     Conversion to controlled-release levodopa/carbidopa treatment and
     quality of life as measured by the Nottingham Health Profile. The Star
     Study Group.
     Neurologia. 1999 Aug-Sep;14(7):338-43.
     PMID: 10570620; UI: 20037198.

 Tsui JK, et al.
     Occupational risk factors in Parkinson's disease.
     Can J Public Health. 1999 Sep-Oct;90(5):334-7.
     PMID: 10570579; UI: 20037157.

 Piccini P, et al.
     Dopamine release from nigral transplants visualized in vivo in a
     Parkinson's patient.
     Nat Neurosci. 1999 Dec;2(12):1137-1140.
     PMID: 10570493.

 Barker RA, et al.
     Functional integration of neural grafts in Parkinson's disease.
     Nat Neurosci. 1999 Dec;2(12):1047-1048.
     PMID: 10570477.

 de Bie RM, et al.
     Unilateral pallidotomy in Parkinson's disease: a randomised,
     single-blind, multicentre trial.
     Lancet. 1999 Nov 13;354(9191):1665-9.
     PMID: 10568567; UI: 20033215.

 Quinn N.
     Progress in functional neurosurgery for Parkinson's disease.
     Lancet. 1999 Nov 13;354(9191):1658-9. No abstract available.
     PMID: 10568561; UI: 20033209.

 Ilic TV, et al.
     Oxidative stress indicators are elevated in de novo Parkinson's
     disease patients.
     Funct Neurol. 1999 Jul-Sep;14(3):141-7.
     PMID: 10568214; UI: 20034209.

 Lin J, et al.
     Absence of G209A and G88C Mutations in the Alpha-Synuclein Gene of
     Parkinson's Disease in a Chinese Population.
     Eur Neurol. 1999 Nov;42(4):217-220.
     PMID: 10567818.

 Hutchinson M, et al.
     Parkinson's disease: a novel MRI method for determining structural
     changes in the substantia nigra.
     J Neurol Neurosurg Psychiatry. 1999 Dec;67(6):815-818.
     PMID: 10567508.

 Sakatani K, et al.
     Changes in cerebral blood oxygenation of the frontal lobe induced by
     direct electrical stimulation of thalamus and globus pallidus: a near
     infrared spectroscopy study.
     J Neurol Neurosurg Psychiatry. 1999 Dec;67(6):769-773.
     PMID: 10567495.

 Rinne JO, et al.
     Usefulness of a dopamine transporter PET ligand [(18)F]beta-CFT in
     assessing disability in Parkinson's disease.
     J Neurol Neurosurg Psychiatry. 1999 Dec;67(6):737-741.
     PMID: 10567489.

 Micek ST, et al.
     Tolcapone: a novel approach to Parkinson's disease.
     Am J Health Syst Pharm. 1999 Nov 1;56(21):2195-205.
     PMID: 10565698; UI: 20029428.

 Dunnett SB.
     Repair of the damaged brain. The alfred meyer memorial lecture 1998.
     Neuropathol Appl Neurobiol. 1999 Oct;25(5):351-62.
     PMID: 10564524; UI: 20032058.

 Meredith GE, et al.
     Immunocytochemical characterization of catecholaminergic neurons in
     the rat striatum following dopamine-depleting lesions.
     Eur J Neurosci. 1999 Oct;11(10):3585-96.
     PMID: 10564366; UI: 20032211.

 Jaber M, et al.
     Differential regulation of tyrosine hydroxylase in the basal ganglia
     of mice lacking the dopamine transporter.
     Eur J Neurosci. 1999 Oct;11(10):3499-511.
     PMID: 10564358; UI: 20032203.

 Maraganore DM, et al.
     Case-control study of the ubiquitin carboxy-terminal hydrolase L1 gene
     in Parkinson's disease.
     Neurology. 1999 Nov 10;53(8):1858-60.
     PMID: 10563640; UI: 20025164.

 [No authors listed]
     Developments in the treatment of Parkinson's disease.
     Drug Ther Bull. 1999 May;37(5):36-40.
     PMID: 10563057; UI: 20028797.

 Phillips NJ, et al.
     Validity of mortality data for Parkinson's disease.
     J Epidemiol Community Health. 1999 Sep;53(9):587-8. No abstract
     available.
     PMID: 10562888; UI: 20028628.

 Iansek R.
     Key points in the management of Parkinson's disease.
     Aust Fam Physician. 1999 Sep;28(9):897-901.
     PMID: 10561888; UI: 20024531.

 Ihara Y, et al.
     Hydroxyl radical and superoxide dismutase in blood of patients with
     Parkinson's disease: relationship to clinical data.
     J Neurol Sci. 1999 Nov 30;170(2):90-95.
     PMID: 10561523.

 Bennett JP.
     Free radicals, oxidative stress and the origin of Parkinson's disease.
     J Neurol Sci. 1999 Nov 30;170(2):75-76. No abstract available.
     PMID: 10561521.

 Galvin JE, et al.
     Axon pathology in Parkinson's disease and lewy body dementia
     hippocampus contains alpha-, beta-, and gamma-synuclein.
     Proc Natl Acad Sci U S A. 1999 Nov 9;96(23):13450-5.
     PMID: 10557341; UI: 20027568.

 Scheife RT.
     Successful orchestration of antiparkinsonian pharmacotherapy.
     Pharmacotherapy. 1999 Nov;19(11 Pt 2):180S-186S.
     PMID: 10555946; UI: 20022872.

 Luer MS.
     Interventions to achieve tonic exposure to levodopa: delaying or
     preventing the onset of motor complications.
     Pharmacotherapy. 1999 Nov;19(11 Pt 2):169S-179S.
     PMID: 10555945; UI: 20022871.

 Gottwald MD.
     Maximizing the benefit: risk ratio of levodopa therapy in Parkinson's
     disease.
     Pharmacotherapy. 1999 Nov;19(11 Pt 2):162S-168S.
     PMID: 10555944; UI: 20022870.

 Lapane KL, et al.
     Prevalence, clinical characteristics, and pharmacologic treatment of
     Parkinson's disease in residents in long-term care facilities. SAGE
     Study Group.
     Pharmacotherapy. 1999 Nov;19(11):1321-7.
     PMID: 10555938; UI: 20022864.

 Schulz JB, et al.
     Molecular pathogenesis of movement disorders: are protein aggregates a
     common link in neuronal degeneration?
     Curr Opin Neurol. 1999 Aug;12(4):433-9.
     PMID: 10555832; UI: 20022758.

 Spacey SD, et al.
     The genetics of Parkinson's disease.
     Curr Opin Neurol. 1999 Aug;12(4):427-32.
     PMID: 10555831; UI: 20022757.

 Krack P, et al.
     Surgical treatment of Parkinson's disease.
     Curr Opin Neurol. 1999 Aug;12(4):417-25.
     PMID: 10555830; UI: 20022756.

 Poewe W.
     Recent advances in the drug treatment of Parkinson's disease.
     Curr Opin Neurol. 1999 Aug;12(4):411-5. No abstract available.
     PMID: 10555829; UI: 20022755.

 Metman LV, et al.
     Amantadine for levodopa-induced dyskinesias: a 1-year follow-up study.
     Arch Neurol. 1999 Nov;56(11):1383-6.
     PMID: 10555659; UI: 20022585.

 Melnick ME, et al.
     Effect of pallidotomy on postural control and motor function in
     Parkinson disease.
     Arch Neurol. 1999 Nov;56(11):1361-5.
     PMID: 10555656; UI: 20022582.

 Murer MG, et al.
     Levodopa in Parkinson's disease: neurotoxicity issue laid to rest?
     Drug Saf. 1999 Nov;21(5):339-52.
     PMID: 10554050; UI: 20019478.

 Papa SM, et al.
     Internal globus pallidus discharge is nearly suppressed during
     levodopa-induced dyskinesias.
     Ann Neurol. 1999 Nov;46(5):732-8.
     PMID: 10553990; UI: 20019418.

 Ouchi Y, et al.
     Presynaptic and postsynaptic dopaminergic binding densities in the
     nigrostriatal and mesocortical systems in early Parkinson's disease: a
     double-tracer positron emission tomography study.
     Ann Neurol. 1999 Nov;46(5):723-31.
     PMID: 10553989; UI: 20019417.
------------------------------------------------------------------------

janet paterson
52 now / 41 dx / 37 onset
http://www.geocities.com/SoHo/Village/6263/
613 256 8340 po box 171 almonte ontario canada k0a 1a0